» Articles » PMID: 34942981

A Cardioplegic Solution with an Understanding of a Cardiochannelopathy

Overview
Date 2021 Dec 24
PMID 34942981
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac surgeries have been improved by accompanying developing cardioplegia solutions. However, the cardioplegia application presents an ongoing challenge with a view of a sufficiently restored cardiac function. In this review, we focus on the cardioplegia-induced mechanism and summarize the findings of studies undertaken to improve cardioprotective strategies. Currently, and somewhat surprisingly, relatively little is known about cardiac electrolyte regulation through channel physiology. We hope that an improved understanding of the electrolyte transport through ion channels/transporters and modulations of water channel aquaporins will provide an insight into cardiac channel physiology and a channel-based cardiac pathology of a cardiochannelopathy.

Citing Articles

Extracellular vesicle therapeutics for cardiac repair.

Hu Y, Zhang W, Ali S, Takeda K, Vahl T, Zhu D J Mol Cell Cardiol. 2024; 199:12-32.

PMID: 39603560 PMC: 11788051. DOI: 10.1016/j.yjmcc.2024.11.005.


Hyperkalemic or Low Potassium Cardioplegia Protects against Reduction of Energy Metabolism by Oxidative Stress.

Diao H, Gu H, Chen Q Antioxidants (Basel). 2023; 12(2).

PMID: 36830011 PMC: 9952220. DOI: 10.3390/antiox12020452.


St. Thomas Modified Cardioplegia Effects on Myoblasts' Viability and Morphology.

Nowicki R, Biezunska-Kusiak K, Kulbacka J, Choromanska A, Daczewska M, Potoczek S Medicina (Kaunas). 2022; 58(2).

PMID: 35208603 PMC: 8879905. DOI: 10.3390/medicina58020280.

References
1.
Sirish P, Ledford H, Timofeyev V, Thai P, Ren L, Kim H . Action Potential Shortening and Impairment of Cardiac Function by Ablation of . Circ Arrhythm Electrophysiol. 2017; 10(10). PMC: 5662469. DOI: 10.1161/CIRCEP.117.005267. View

2.
Baumgartner M, Patel H, Barber D . Na(+)/H(+) exchanger NHE1 as plasma membrane scaffold in the assembly of signaling complexes. Am J Physiol Cell Physiol. 2004; 287(4):C844-50. DOI: 10.1152/ajpcell.00094.2004. View

3.
De Simone G, Di Fiore A, Supuran C . Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs?. Curr Pharm Des. 2008; 14(7):655-60. DOI: 10.2174/138161208783877820. View

4.
Hatakeyama S, Yoshida Y, Tani T, Koyama Y, Nihei K, Ohshiro K . Cloning of a new aquaporin (AQP10) abundantly expressed in duodenum and jejunum. Biochem Biophys Res Commun. 2001; 287(4):814-9. DOI: 10.1006/bbrc.2001.5661. View

5.
Vargas L, Alvarez B . Carbonic anhydrase XIV in the normal and hypertrophic myocardium. J Mol Cell Cardiol. 2012; 52(3):741-52. DOI: 10.1016/j.yjmcc.2011.12.008. View